Trade OBX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Obsidian Therapeutics, Inc. (OBX) is trading at US$12.24, down 7.27% today as of Oct 8, 16:00 EDT. The company has a market capitalisation of US$1.23B. Over the past 52 weeks, OBX has traded between US$12.07 and US$49.97. On Syfe you can trade OBX with $0 commission and add it to your watchlist.
| Previous close | US$13.20 |
|---|---|
| Market cap | US$1.23B |
| 52-week range | US$12.07 – US$49.97 |
| Volume | 517.06K |
| Exchange | US |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.
Year: 2026
--TD Cowen Initiates Obsidian Therapeutics at Buy
Aug 6, 11:19 AM · MT Newswires
--Piper Sandler Initiates Obsidian Therapeutics at Overweight
Aug 5, 11:18 AM · MT Newswires
Obsidian Therapeutics, Inc. (OBX) stock is trading at US$12.24, -7.27% from the previous close of US$13.20.
The market cap for Obsidian Therapeutics, Inc. (OBX) stock is approximately US$1.23B.
The 52-week high for Obsidian Therapeutics, Inc. (OBX) stock is US$49.97.
The 52-week low for Obsidian Therapeutics, Inc. (OBX) stock is US$12.07.
Obsidian Therapeutics, Inc. (OBX) does not currently pay a dividend.
Stay on top of OBX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
